Study
PELICAN33 longitudinal clinical and autopsy phenomic assessment in lethal metastatic prostate cancer
| Study ID | Alternative Stable ID | Type |
|---|---|---|
| EGAS00001005399 | Other |
Study Description
Objective: To identify novel phenotypes and features associated with metastatic prostate cancer (mPC) outcome, and to identify biomarker and data requirements to be tested in future precision oncology trials.
Design, Setting, and Participants: We analyzed deep longitudinal clinical, neuroendocrine expression, and autopsy data of 33 men who died from mPC between 1995 and 2004 (PELICAN33), and related findings to mPC biomarkers reported in the literature.
Intervention: 33 men prospectively consented to participate in an integrated clinical-molecular rapid autopsy study of mPC.
Study Datasets 1 dataset.
Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data
| Dataset ID | Description | Technology | Samples |
|---|---|---|---|
| EGAD00001007800 |
To better understand variation in metastatic prostate cancer behaviour, we assembled and analyzed longitudinal clinical and autopsy records in 33 men. The dataset is contained in a self-explanatory Excel Workbook, with each patient identified as A1, A2, etc. as listed in the "Combined longitudinal clinical and autopsy phenomic assessment in lethal metastatic prostate cancer: recommendations for advancing precision medicine" publication in European Urology Open Science. Please see Jasu J, ... (Show More)
|
33 |
Who archives the data?
Publications
Citations
Retrieving...
Retrieving...
